Biomunex
  • HOME
  • COMPANY
    • ABOUT BIOMUNEX
    • TEAM
    • STRATEGIC BOARD AND KEY ADVISORS
    • FUNDING AND GRANTS
  • TECHNOLOGIES AND PRODUCTS
    • ANTIBODY THERAPEUTICS
    • BiXAb® TECHNOLOGY
    • BI- AND MULTI-SPECIFIC ANTIBODIES DEVELOPED BY BIOMUNEX
    • PIPELINE
    • INTELLECTUAL PROPERTY
    • PUBLICATIONS AND PRESENTATIONS
  • PARTNERING
    • ACADEMIC AND INSTITUTIONAL COLLABORATIONS
    • INDUSTRIAL PARTNERSHIP AGREEMENTS
    • DEVELOPMENT AND LICENSE AGREEMENTS
    • MEET US
  • CAREERS
  • NEWS
    • PRESS RELEASES
    • MEDIA
  • CONTACT
Menu Fermer
  • HOME
  • COMPANY
    • ABOUT BIOMUNEX
    • TEAM
    • STRATEGIC BOARD AND KEY ADVISORS
    • FUNDING AND GRANTS
  • TECHNOLOGIES AND PRODUCTS
    • ANTIBODY THERAPEUTICS
    • BiXAb® TECHNOLOGY
    • BI- AND MULTI-SPECIFIC ANTIBODIES DEVELOPED BY BIOMUNEX
    • PIPELINE
    • INTELLECTUAL PROPERTY
    • PUBLICATIONS AND PRESENTATIONS
  • PARTNERING
    • ACADEMIC AND INSTITUTIONAL COLLABORATIONS
    • INDUSTRIAL PARTNERSHIP AGREEMENTS
    • DEVELOPMENT AND LICENSE AGREEMENTS
    • MEET US
  • CAREERS
  • NEWS
    • PRESS RELEASES
    • MEDIA
  • CONTACT
Skip to content

STRATEGIC BOARD AND KEY ADVISORS

STRATEGIC BOARD

Pierre-Emmanuel GERARD, MD, MBA

Founder, President and CEO, Chairman of the Board

C. Grace YEH, PhD

Member of the Strategic Board

Jordi ESCLUSA

Member of the Strategic Board

Alain DUBLIN

Member of the Strategic Board

Tony SEDGWICK, PhD FRCPath

Independent member of the Strategic Board

SCIENTIFIC ADVISORY BOARD

Simon PLYTE, PhD

Chief Scientific Officer (CSO) and member of the Scientific Advisory Board (SAB)

Dr. Sebastian AMIGORENA, PhD

Key Scientific Advisor and member of the Scientific Advisory Board

Olivier LANTZ, PhD

Scientific Advisor and member of the
Scientific Advisory Board

Matthias PEIPP, PhD

Scientific Advisor and member of the
Scientific Advisory Board

CONTACT

CAREERS

PRIVACY POLICY BIOMUNEX

LEGAL INFORMATION